Michael Festa is the chief financial officer for Xerox Services. He was named to this position in January 2012. Festa was appointed as corporate vice president of Xerox in October 2010. In this position, Festa oversees financial operations for the Services Business Group ensuring adequate internal controls, financial discipline and integrity.

Prior to this appointment, Festa was vice president of business transformation, finance, mergers and acquisitions for the Xerox Global Customer Operations Group. He managed Xerox’s acquisition investments, valuation analysis and negotiations as well as the company’s intellectual property operations. In addition, he was responsible for driving Global Customer Operations infrastructure and business transformation initiatives, including managed print services, remote services and offering simplification.

Festa joined Xerox in 1990 and has held a variety of positions in finance, which includes serving as chief financial officer of both Xerox Europe and Developing Markets Operations, finance executive for the Production Systems Group, and director of corporate financial planning and analysis. Before joining Xerox, he served as a manager at Deloitte and Touche.

Festa holds a bachelor’s degree in accounting from Seton Hall University and is a Certified Public Accountant.

Ann Davison has an accomplished career as a communications and public affairs advisor to elected officials, government program officers, corporate executives, trade association and nonprofit leaders. She is recognized for creating impact-focused public education campaigns, bringing fresh insights to citizen engagement challenges and driving multiple stakeholders towards common goals.

Ann currently serves as a Director in the Public Sector division of PricewaterhouseCooper where she advises federal agencies and large nonprofit institutions on strategies to more effectively engage the public and key stakeholders. She was recently selected to help lead a team providing public relations and crisis management counsel to U.S. Census Bureau in preparation for the 2020 Decennial with the goal of maximizing public participation.

Ann spent 15 years of her career as a senior leader with two of the nation’s leading public relations firms. As the Chair of the U.S. Public Affairs and Crisis Practice at Burson-Marsteller, Ann led an award-winning crisis management and reputation recovery campaign for the first U.S. hospital to diagnose a patient with Ebola and was invited by the Rockefeller Foundation to share learnings at an international gathering of crisis communications professionals. At Fleishman-Hillard, Ann led ground-breaking integrated communications campaigns to improve public health on behalf of federal government agencies and with private sector clients to create signature corporate citizenship programs and thought leadership platforms with a focus on sustainability and education.

Ann’s public sector experience includes serving as an advisor to EPA Administrator Carol M. Browner in the Clinton-Gore Administration, managing an interagency task force on food safety reform. She regularly briefed Cabinet Members, Congressional staff and media on EPA initiatives and was detailed to the Office of the Vice President to lead communications for a ground-breaking international science and environmental education program.

Prior to joining the Administration, Ann provided legislative counsel and constituent relations support for Florida Senators Lawton Chiles and Bob Graham.

A graduate of Duke University (BA) and Johns Hopkins University (MA), Ann is  the Development Committee Chair for the Duke University Student Publishing Company and a leader with Women in Government Relations.

Husseini K. Manji, MD, FRCPC is Global Therapeutic Head for Neuroscience at Janssen Research & Development, LLC, one of the Johnson & Johnson pharmaceutical companies. He is also Visiting Professor at Duke University. Dr. Manji was previously Chief of the Laboratory of Molecular Pathophysiology & Experimental Therapeutics at the National Institutes of Health (NIH) and Director of the NIH Mood and Anxiety Disorders Program, the largest program of its kind in the world.

The major focus of Dr. Manji’s world-renowned research is the investigation of disease- and treatment-induced changes in gene and protein networks that regulate synaptic and neural plasticity in neuropsychiatric disorders. His work has helped to conceptualize these illnesses as genetically-influenced disorders of synaptic and neural plasticity and has led to the investigation of novel therapeutics for refractory patients. Dr. Manji has also been actively involved in developing biomarkers to help refine these multifactoral diseases.

Dr. Manji has received a number of prestigious awards, including the NIMH Director’s Career Award for Significant Scientific Achievement, the A. E. Bennett Award for Neuropsychiatric Research, the Ziskind-Somerfeld Award for Neuropsychiatric Research, the NARSAD Mood Disorders Prize, the Mogens Schou Distinguished Research Award, the ACNP’s Joel Elkes Award for Distinguished Research, the DBSA Klerman Senior Distinguished Researcher Award, the American Federation for Aging Research Award of Distinction, and the Global Health & the Arts Award of Recognition. In 2017, he was recognized as one of 14 inaugural “Health Heroes” by Oprah magazine.

Dr. Manji has been inducted into the National Academy of Sciences’ Institute of Medicine (IOM) and has held numerous leadership positions within the IOM, the NIH Biomarkers Neuroscience Steering Committee, the ACNP, and the Society of Biological Psychiatry.

Throughout his career, Dr. Manji has also been committed to undertakings related to medical and neuroscience education and has worked with the National Board of Medical Examiners (NBME), the Howard Hughes Medical Institute Research Scholars Program, and numerous national curriculum committees. He founded and co-directed the NIH Foundation for the Advanced Education in the Sciences Graduate Course in the Neurobiology of Neuropsychiatric Illness, and has received several teaching and mentoring awards. In addition to serving on the editorial board of numerous journals, Dr. Manji has been Editor of Neuropsychopharmacology Reviews, Deputy Editor of Biological Psychiatry, and Associate Editor of Bipolar Disorders.